Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

873 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Virtual Reality Telerehabilitation for Postural Instability in Parkinson's Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial.
Gandolfi M, Geroin C, Dimitrova E, Boldrini P, Waldner A, Bonadiman S, Picelli A, Regazzo S, Stirbu E, Primon D, Bosello C, Gravina AR, Peron L, Trevisan M, Garcia AC, Menel A, Bloccari L, Valè N, Saltuari L, Tinazzi M, Smania N. Gandolfi M, et al. Among authors: trevisan m. Biomed Res Int. 2017;2017:7962826. doi: 10.1155/2017/7962826. Epub 2017 Nov 26. Biomed Res Int. 2017. PMID: 29333454 Free PMC article. Clinical Trial.
Consensus paper on postural dysfunction: recommendations for prevention, diagnosis and therapy.
Saggini R, Anastasi GP, Battilomo S, Maietta Latessa P, Costanzo G, Di Carlo F, Festa F, Giardinelli G, Macrì F, Mastropasqua L, Nardone M, Nicoletti G, Orsini A, Pastorelli M, Pellegrino R, Trevisan M, La Mesa L, Le Pera AM, Privitera MG, Ralli G, Villani C, Bricot B, Davidson RG, Hassdenteufel A, Hawamdeh ZM, Kleinrensink GJ, Matheron E, Stoev VL, Stratulat S, Tiron S, Villeneuve P, Paolucci T, Bellomo RG. Saggini R, et al. Among authors: trevisan m. J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2):441-456. doi: 10.23812/20-743-A. J Biol Regul Homeost Agents. 2021. PMID: 33940790
Data-Driven Thyroglobulin Cutoffs for Low- and Intermediate-Risk Thyroid Cancer Follow-Up: ITCO Real-World Analysis.
Grani G, D'Elia S, Puxeddu E, Morelli S, Arvat E, Nervo A, Spiazzi G, Rolli N, Zatelli MC, Ambrosio MR, Ceresini G, Marina M, Mele C, Aimaretti G, Santaguida MG, Virili C, Crescenzi A, Palermo A, Giaccherino RR, Meomartino L, Castagna MG, Maino F, Trevisan M, De Leo S, Chiofalo MG, Pezzullo L, Sparano C, Petrone L, Dalmazi GD, Napolitano G, Tumino D, Crocetti U, Bertagna F, Deandrea M, Antonelli A, Mian C, Carbone A, Monti S, Porcelli T, Brigante G, Barbaro D, Alfò M, Ferraro Petrillo U, Filetti S, Durante C. Grani G, et al. Among authors: trevisan m. J Clin Endocrinol Metab. 2024 Aug 16:dgae559. doi: 10.1210/clinem/dgae559. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39150986
Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer.
Roubaud G, Attard G, Boegemann M, Olmos D, Trevisan M, Antoni L, Pascoe K, Capone C, Van Sanden S, Hashim M, Palmer S, Chi K. Roubaud G, et al. Among authors: trevisan m. Eur J Cancer. 2024 Sep;209:114183. doi: 10.1016/j.ejca.2024.114183. Epub 2024 Jun 17. Eur J Cancer. 2024. PMID: 39111209 Clinical Trial.
Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer.
De Santis M, Breijo SM, Robinson P, Capone C, Pascoe K, Van Sanden S, Hashim M, Trevisan M, Daly C, Reitsma F, van Beekhuizen S, Ruan H, Heeg B, Verzoni E. De Santis M, et al. Among authors: trevisan m. Adv Ther. 2024 Aug;41(8):3039-3058. doi: 10.1007/s12325-024-02918-6. Epub 2024 Jul 3. Adv Ther. 2024. PMID: 38958846 Free PMC article. Review.
Listener effort quantifies clinically meaningful progression of dysarthria in people living with amyotrophic lateral sclerosis.
Bingham IN, Norel R, Roitberg EG, Peller J, Trevisan MA, Agurto C, Shalom DE, Aguirre F, Embon I, Taitz A, Harris D, Wright A, Seaver K, Sullivan S, Green JR, Ostrow LW, Fraenkel E, Berry JD. Bingham IN, et al. Among authors: trevisan ma. medRxiv [Preprint]. 2024 Jun 1:2024.05.31.24308140. doi: 10.1101/2024.05.31.24308140. medRxiv. 2024. PMID: 38853969 Free PMC article. Preprint.
873 results